Last quarter (Q3 2024), Unity Biotechnology's total revenue was $1.07M, an increase of 9.32% from the same quarter last year. In Q3, Unity Biotechnology's net income was $-6.48M. See Unity Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 4.01M	$ ―	$ 236.00K	$ 4.78M	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 4.01M	$ ―	$ 236.00K	$ 4.78M	$ ―	$ ―
Operating Expense	$ 28.30M	$ 44.67M	$ 57.81M	$ 61.45M	$ 93.93M	$ 89.65M
Operating Income	$ -28.30M	$ -44.67M	$ -57.57M	$ -56.66M	$ -93.93M	$ -89.65M
Net Non Operating Interest Income Expense	$ 1.95M	$ 422.00K	$ -2.34M	$ -3.08M	$ -96.00K	$ 3.29M
Other Income Expense	$ 1.32M	$ 7.43M	$ 15.44M	$ 983.00K	$ 2.45M	$ -4.18M
Pretax Income	$ -20.08M	$ -39.86M	$ -44.47M	$ -60.73M	$ -93.91M	$ -84.88M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -19.05M	$ -39.86M	$ -44.47M	$ -60.73M	$ -93.84M	$ -84.88M
Basic EPS	$ -1.24	$ -2.70	$ -6.31	$ -10.90	$ -18.40	$ -18.80
Diluted EPS	$ -1.24	$ -2.70	$ -6.31	$ -10.90	$ -18.40	$ -18.80
Basic Average Shares	$ 66.21M	$ 14.77M	$ 9.49M	$ 5.58M	$ 5.09M	$ 4.36M
Diluted Average Shares	$ 66.21M	$ 14.77M	$ 9.49M	$ ―	$ 5.09M	$ 4.36M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 28.30M	$ 44.67M	$ 57.81M	$ 61.45M	$ 93.93M	$ 89.65M
Net Income From Continuing And Discontinued Operation	$ -19.05M	$ -39.86M	$ -44.47M	$ -60.73M	$ -93.84M	$ -82.18M
Normalized Income	$ -12.66M	$ ―	$ ―	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -19.05M	$ -37.41M	$ -40.91M	$ -57.55M	$ -92.55M	$ -84.88M
EBITDA	$ -17.89M	$ -36.23M	$ -38.73M	$ -52.81M	$ -89.10M	$ -83.37M

Currency in USD

Unity Biotechnology Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing